Volcano Corporation VOLC shares soared over 50 percent following news that it will be acquired by Royal Philips NV for approximately $1 billion.
"Volcano's impressive and unique product portfolio is highly complementary to our strong offering in live image- guidance solutions, creating an opportunity to accelerate the revenue growth for our image-guided therapy business to a high single-digit rate by 2017," according to Philips' Chief Executive Frans van Houten.
Dow Jones reported that Volcano is the market leader in making flexible tubes that can produce ultrasound images of blood vessels as well as consoles to measure blood flow. The San Diego, Calif.-based firm, which aims to make products to help treat cardiovascular diseases in less invasive ways, reported sales last year of about $400 million.
Another company in the cardiovascular medical device business is Spectranetics Corp SPNC which has a similar market capitalization to Volcano. The company manufactures devices for minimally invasive cardiovascular procedures and its stock is up 34.32 percent Year-to-Date.
Larger competitors include St. Jude Medical, Inc. STJ and Boston Scientific Corporation BSX.
Volcano Corporation recently traded at $17.83, up 55.19 percent.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
